SEC 13F Intelligence

Acadian Asset Management LLC / BIO

Acadian Asset Management LLC’s Bio Rad Labs Inc Position

Does Acadian Asset Management LLC own Bio Rad Labs Inc (BIO)? Yes102.8K shares worth $29M (+0.04% of its 13F portfolio) as of Q1 2026, down from 120.6K shares the prior filed quarter.

Position Value
$29M
Q1 2026
Shares
102.8K
% of Portfolio
+0.04%
Quarters Held
27
currently held

Position History BIO

Reported value by quarter
Q4 ’18: $144MQ4 ’18Q1 ’19: $157MQ3 ’19: $123MQ2 ’20: $120MQ3 ’20: $125MQ3 ’20Q4 ’20: $142MQ1 ’21: $165MQ2 ’21: $249MQ3 ’21: $315MQ3 ’21Q4 ’21: $311MQ1 ’22: $234MQ2 ’22: $199MQ3 ’22: $164MQ3 ’22Q4 ’22: $140MQ1 ’23: $119MQ2 ’23: $47MQ3 ’23: $13MQ3 ’23Q4 ’23: $9MQ1 ’24: $7MQ2 ’24: $796,000Q3 ’24: $601,000Q3 ’24Q4 ’24: $13MQ1 ’25: $18MQ2 ’25: $12MQ3 ’25: $39MQ3 ’25Q4 ’25: $37MQ1 ’26: $29Mfilingsflow.com
QuarterSharesValue% of Portfolio
Q1 2026102.8K$29M+0.04%
Q4 2025120.6K$37M+0.06%
Q3 2025138.9K$39M+0.07%
Q2 202551.4K$12M+0.03%
Q1 202573.4K$18M+0.05%
Q4 202440.9K$13M+0.04%
Q3 20241.8K$601,0000.00%
Q2 20242.9K$796,0000.00%
Q1 202419.1K$7M+0.02%
Q4 202326.7K$9M+0.03%
Q3 202335.4K$13M+0.05%
Q2 2023123.0K$47M+0.19%
Q1 2023248.5K$119M+0.52%
Q4 2022333.3K$140M+0.69%
Q3 2022392.7K$164M+0.90%
Q2 2022403.0K$199M+1.02%
Q1 2022415.5K$234M+0.96%
Q4 2021411.5K$311M+1.16%
Q3 2021422.9K$315M+1.20%
Q2 2021386.8K$249M+0.94%
Q1 2021289.0K$165M+0.64%
Q4 2020243.3K$142M+0.55%
Q3 2020243.0K$125M+0.52%
Q2 2020265.4K$120M+0.52%
Q3 2019370.6K$123M+0.53%
Q1 2019513.4K$157M+0.68%
Q4 2018619.0K$144M+0.71%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Acadian Asset Management LLC’s full portfolio or all institutional holders of BIO.